Director, Market Access Obesity & MASH (Region EUCAN)

Market access is about pushing boundaries. This is more than a role, it’s an opportunity to be part of our unwavering commitment to drive change, creating impact today while shaping the future of patient care.

Your new role

As the Director for Region EUCAN Market Access, Obesity & MASH within the Region EUCAN Pricing & Market Access department, you will be sitting at the intersection of strategy, innovation, and patient affordability, going beyond traditional pricing and reimbursement to redefine how access is created across diverse payer systems.

Leading an outstanding team of three experts, this is a unique opportunity to shape market access at scale for some of the most transformative therapies in obesity and liver disease. With broad regional influence across EUCAN and high-visibility assets, you’ll set new standards for out-of-pocket mitigation, evidence-led access, and cross-sector collaboration.

Your main responsibilities include:

• Leading the Region EUCAN (Europe & Canada) Market Access strategy for the Obesity and MASH portfolios, ensuring alignment across markets and functions
• Designing and implementing innovative out-of-pocket mitigation and affordability strategies to enable sustainable access for key assets
• Developing tailored access approaches across public payers, private insurers, employer-sponsored plans, and self-pay channels, adapting to diverse healthcare systems
• Shaping pricing and contracting frameworks, including outcomes-based agreements and novel public–private access models
• Driving evidence generation initiatives (e.g. RWE studies and pilots) to demonstrate value and support reimbursement decisions
• Engaging senior stakeholders across HTA bodies, payers, policymakers, patient groups, and professional societies to influence coverage and benefit design
• Providing senior-level leadership and cross-functional coordination across Region EUCAN to maximize both patient impact and commercial value.

Your new department,

Region EUCAN Market Access, Obesity & MASH department develops and implements reimbursement, access and commercial strategies to ensure patients living with obesity and liver diseases can benefit from our therapies. Aligned with our purpose to improve patients’ lives, the team drives clinical, evidence and stakeholder initiatives, and engages colleagues across the organisation to lead change and secure sustainable access.

You will join Pricing & Market Access, where we support our stakeholders to solve various business challenges related to medicine pricing and affordability across various geographies across Region EUCAN.

Your skills and qualifications

We are seeking a strategic, driven leader who thrives in complex, fast-paced environments. You excel in collaboration, influence diverse stakeholders with confidence, and maintain focus while balancing long-term vision with execution. You combine a strong value- and patient-centric mindset with everything you do. Also, you bring with you:

• A degree (M.Sc. or PhD) in Health Economics, Public Health, Business Administration, or a related field,
• Extensive senior-level experience in market access in the pharmaceutical, biotech or consumer health industry. Experience in obesity, MASH or related cardiometabolic areas is a big advantage.
• Demonstrated experience with complex pricing, contracting, and out-of-pocket mitigation strategies across public and private payer settings
• Deep expertise in international market access, with a proven track record of securing reimbursement and formulary access for high-value therapies
• Demonstrated leadership in matrix and cross‑functional environments. Previous experience as people manager is a plus.
• Excellent communication and negotiation skills, with fluency in spoken and written English and confidence engaging senior stakeholders

Working at Novo Nordisk 

Every day we seek the solutions that defeat serious chronic diseases. To do this, we approach our work with an unconventional spirit, a rare determination, and a constant curiosity. For over 100 years, this mindset has seen us build a company unlike any other. One where a collective passion for our purpose, mutual respect and a willingness to go beyond what we know delivers extraordinary results. 

What we offer 

There is, of course, more on offer here than the uniqueness of our culture and the extraordinary results we produce. Being part of a global healthcare company means opportunities to learn and develop are all around us, while our benefits are designed with your career and life stage in mind.

• Salary: For this role, the Annual Base Salary ranges from 1,034,790.00 y 1,593,550.00 DKK, corresponding to the level of the position.
  The placement within the salary range will be assessed during the recruitment process based on the candidate’s skills, competencies, knowledge, and relevant experience.
• Incentives and Benefits: The salary package may include short-term and/or long-term incentives as well as other employee benefits based on position level, location, functional area and relevant market benchmarks.

Learn more about our Reward Philosophy here.

 
Deadline to apply 
June 18th 2026. Applications will be reviewed on an ongoing basis, so we encourage you to apply as soon as possible. 

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.

At Novo Nordisk, we're not chasing quick fixes – we're creating lasting change for long-term health. For over 100 years, we've been driven by a single purpose: to defeat serious chronic diseases and help millions of people live healthier lives. This dedication fuels our constant curiosity and inspires us to push the boundaries of what's possible in healthcare. We embrace diverse perspectives, seek out bold ideas, and build partnerships rooted in shared purpose. Together, we're making healthcare more accessible, treating and preventing diseases, and pioneering solutions that create change spanning generations. When you join us, you become part of something bigger – a legacy of impact that reaches far beyond today.